<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    June 25, 2011

    Supreme Court 5-4 and 6-3 Victories for the Drug Discovery Business



    Two rulings by the Supreme Court earlier this week provide some positive news for the drug discovery business. The first ruling minimizes patient litigation against makers of generic drugs. Generic drug makers use the same warning label as the initial company that discovered the drug. The court basically says it trusts the FDA’s judgement on warning labels – and generic drug companies can not be suited under state law. The second ruling allows more targeted marketing from pharmaceutical companies to doctors based on their prescription records.

    Here is a nice article by 2009 Pulitzer Prize Finalist Adam Liptak in the NY Times summarizing the court’s debate.

    For an analysis of the implications for the original organization that discovered the drug vs generic manufactures, see “Generic Drug Warning Labels: The Supreme Court Speaks” from Derek Lowe’s widely read In The Pipeline blog.




    This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!

    CDD Vault: Drug Discovery Informatics your whole project team will embrace!

    Tag(s): CDD Blog

    Other posts you might be interested in

    View All Posts
    CDD Blog
    9 min   April 19, 2024
    Drug Discovery Industry Roundup with Barry Bunin — April 19, 2024
    Read More
    CDD Blog
    2 min   April 19, 2024
    CDD Appoints Yasushi Hamagashira as Head of Sales and Marketing for Japan
    Read More
    24 min   April 19, 2024
    Recap of CDD 20th Anniversary UGM – South San Francisco 2024
    Read More